Stablepoint Partners LLC Sells 1,099 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Stablepoint Partners LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 20.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,356 shares of the healthcare conglomerate’s stock after selling 1,099 shares during the period. Stablepoint Partners LLC’s holdings in UnitedHealth Group were worth $2,204,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Novare Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.0% during the 4th quarter. Novare Capital Management LLC now owns 46,688 shares of the healthcare conglomerate’s stock worth $23,618,000 after buying an additional 451 shares during the period. Harrell Investment Partners LLC boosted its holdings in UnitedHealth Group by 104.5% during the fourth quarter. Harrell Investment Partners LLC now owns 13,713 shares of the healthcare conglomerate’s stock valued at $6,937,000 after acquiring an additional 7,007 shares during the period. Clarendon Private LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $1,307,000. Crescent Grove Advisors LLC boosted its stake in UnitedHealth Group by 5.5% during the 4th quarter. Crescent Grove Advisors LLC now owns 1,251 shares of the healthcare conglomerate’s stock valued at $633,000 after purchasing an additional 65 shares during the period. Finally, KFG Wealth Management LLC increased its position in UnitedHealth Group by 8.6% in the 4th quarter. KFG Wealth Management LLC now owns 2,036 shares of the healthcare conglomerate’s stock worth $1,030,000 after buying an additional 162 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE UNH opened at $532.26 on Monday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm’s 50-day simple moving average is $541.04 and its 200 day simple moving average is $564.34. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.58%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Bank of America lowered their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.